Contrasting effects of platelet-derived growth factor (PDGF) isomers on mitogenesis, contraction and intracellular calcium concentration in human vascular smooth muscle

Acta Physiologica Scandinavica

Volumn 164, Issue 2, 1998, Pages 191-199

  Hafizi, S ^a   Nobin, R ^b   Allen, S P ^a   Chester, A H ^a   Yacoub, M H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Calcium; Cell; Contraction; Human; Platelet derived growth factor; Proliferation; Vascular smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM ION; DNA; ENDOTHELIN 1; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SEROTONIN; THYMIDINE;

ARTERY INTIMA PROLIFERATION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; MUSCLE FIBER CULTURE; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANTICOAGULANTS; CALCIUM; CELL DIVISION; CORONARY VESSELS; DNA; ENDOTHELIN-1; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; ISOMERISM; MITOGENS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; SAPHENOUS VEIN; THAPSIGARGIN; VASOCONSTRICTION;

EID: 0031727792     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1998.00424.x     Document Type: Article

References (37)

1. Allen, S., Khan, S., Al-Mohanna, F., Batten, P. & Yacoub, M. 1998. Native low density lipoprotein-induced calcium transients tngger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 101, 1064-1075.
2. Assender, J.W., Irenius, E. & Fredholm, B.B. 1996. Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells. Acta Physiol Scand 157, 451-460.
3. Barrett, T.B. & Benditt, E.P. 1987. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA 84, 1099-1103.
4. Berk, B.C., Alexander, R.W., Brock, T.A., Gimbrone Jr., M.A. & Webb, R.C. 1986. Vasoconstriction: a new activity for platelet-derived growth factor. Science 232, 87-90.
5. Berk, B.C., Vekshtein, V., Gordon, H.M. & Tsuda, T. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13, 305-314.
6. Bowen-Pope, D.F., Hart, C.E. & Seifert, R.A. 1989. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 264, 2502-2508.
7. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation 87, 874-880.
8. Clunn, G.F., Refson, J.S., Lymn, J.S. & Hughes, A.D. 1997. Platelet-derived growth factor β-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17, 2622-2629.
9. Daemen, M.J.A.P., Lombardi, D.M., Bosman, F.T. & Schwartz, S.M. 1991. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68, 450-456.
10. Davies, M.G. & Hagen, P.O. 1994. Pathobiology of intimal hyperplasia. Br J Surg 81, 1254-1269.
11. Eriksson, A., Siegbahn, A., Westermark, B., Heldin, C.H. & Claesson-Welsh, L. 1992. PDGF α-and β-receptors activate unique and common signal transduction pathways. EMBO J 11, 543-550.
12. Fager, G., Hansson, G.K., Ottosson, P., Dahllöf, B. & Bondjers, G. 1988. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res 176, 319-335.
13. Ferns, G.A.A., Raines, E.W., Sprugel, K.H., Motani, A.S., Reidy, M.A. & Ross, R. 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
14. Grynkiewicz, G., Poenie, M. & Tsien, R.Y. 1985. A new generation of Ca indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450.
15. 1 receptor blockade. Coron Artery Dis 9, 167-175.
16. Hafizi, S., Chester, A.H. & Yacoub, M.H. 1997. Molecular mechanisms of vascular smooth muscle cell growth. Curr Opin Cardiol 12, 495-503.
17. Hart, C.E., Bailey, M., Curtis, D.A. et al. 1990. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29, 166-172.
18. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br J Pharmacol 114, 138-142.
19. Hughes, A.D., Clunn, G.F., Refson, J. & Demoliou-Mason, C. 1996. Platelet-derived growth factor: actions and mechanisms in vascular smooth muscle. Gen Pharmac 27, 1079-1089.
20. Hughes, A.D., Patel, M., Wijetunge, S., Clunn, G. & Schachter, M. 1995. Comparison of effects of platelet-derived growth factor isoforms on signaling and DNA synthesis of human cultured saphenous vein cells. J Cardiovasc Pharmacol 25, 481-485.
21. Kondo, T., Konishi, F., Inui, H. & Inagami, T. 1993. Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J Biol Chem 268, 4458-4464.
22. Kraiss, L.W., Raines, E.W., Wilcox, J.N. et al. 1993. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 92, 338-348.
23. Krettek, A., Fager, G., Jernberg, P., Östergren-Lundén, G. & Lustig, F. 1997. Quantitation of platelet-derived growth factor receptors in human arterial smooth muscle cells in vitro. Arterioscler Thromb Vasc Biol 17, 2395-2404.
24. Mii, S., Khalil, R.A., Morgan, K.G., Ware, J.A. & Kent, K.C. 1996. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol 270, H142-H150.
25. Mogami, H. & Kojima, I. 1993. Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. Biochem Biophys Res Commun 196, 650-658.
26. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362, 801-809.
27. Ross, R., Raines, E.W. & Bowen-Pope, D.F. 1986. The biology of platelet-derived growth factor. Cell 46, 408-412.
28. Sachinidis, A., Locher, R., Hoppe, J. & Vetter, W. 1990a. The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett 275, 95-98.
29. Sachinidis, A., Locher, R., Vetter, W., Tatje, D. & Hoppe, J. 1990b. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem 265, 10238-10243.
30. Seifert, R.A., Hart, C.H., Phillips, P.E. et al. 1989. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264, 8771-8778.
31. Strauer, B.E. 1979. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44, 999-1006.
32. Tanizawa, S., Ueda, M., van der Loos, C.M., van der Wal, A.C. & Becker, A.E. 1996. Expression of platelet derived growth factor B chain and β-receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart 75, 549-556.
33. 2+ (+)-ATPase. Proc Natl Acad Sci USA 87, 2466-2470.
34. Waltenberger, J. 1997. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases. Circulation 96, 4083-4094.
35. Weber, H., Webb, M.L., Serafino, R. et al. 1994. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 8, 148-158.
36. Yang, Z., Noll, G. & Lüscher, T.F. 1993. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Circulation 88, 832-836.
37. Yang, Z., Oemar, B.S., Carrel, T., Kipfer, B., Julmy, F. & Lüscher, T.F. 1998. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels. Role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 97, 181-187.